These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10025882)

  • 1. Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention.
    Winde G; Lügering N; Glodny B; Schmid KW; Müller O; Senninger N; Osswald H
    Cancer Lett; 1998 Dec; 134(2):201-7. PubMed ID: 10025882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
    Giardiello FM; Spannhake EW; DuBois RN; Hylind LM; Robinson CR; Hubbard WC; Hamilton SR; Yang VW
    Dig Dis Sci; 1998 Feb; 43(2):311-6. PubMed ID: 9512123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
    Winde G; Schmid KW; Brandt B; Müller O; Osswald H
    Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
    Winde G; Schmid KW; Schlegel W; Fischer R; Osswald H; Bünte H
    Dis Colon Rectum; 1995 Aug; 38(8):813-30. PubMed ID: 7634976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.
    Cruz-Correa M; Hylind LM; Romans KE; Booker SV; Giardiello FM
    Gastroenterology; 2002 Mar; 122(3):641-5. PubMed ID: 11874996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.
    Keller JJ; Offerhaus GJ; Polak M; Goodman SN; Zahurak ML; Hylind LM; Hamilton SR; Giardiello FM
    Gut; 1999 Dec; 45(6):822-8. PubMed ID: 10562579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
    Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
    Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.
    Yang VW; Geiman DE; Hubbard WC; Spannhake EW; Hylind LM; Hamilton SR; Giardiello FM
    Prostaglandins Other Lipid Mediat; 2000 Jan; 60(1-3):83-96. PubMed ID: 10680778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
    Fernández-López F; Conde-Freire R; Cadarso-Suárez C; García-Iglesias J; Puente-Domínguez JL; Potel-Lesquereux J
    Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
    Mahmoud NN; Boolbol SK; Dannenberg AJ; Mestre JR; Bilinski RT; Martucci C; Newmark HL; Chadburn A; Bertagnolli MM
    Carcinogenesis; 1998 Jan; 19(1):87-91. PubMed ID: 9472698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.
    Hisamuddin IM; Wehbi MA; Chao A; Wyre HW; Hylind LM; Giardiello FM; Yang VW
    Clin Cancer Res; 2004 Dec; 10(24):8357-62. PubMed ID: 15623613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprevention of familial cancer].
    Ishikawa H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.
    Winde G; Gumbinger HG; Osswald H; Kemper F; Bünte H
    Int J Colorectal Dis; 1993 Mar; 8(1):13-7. PubMed ID: 8388011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of familial adenomatous polyposis.
    Lynch PM
    Fam Cancer; 2016 Jul; 15(3):467-75. PubMed ID: 27083160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.
    Giardiello FM; Casero RA; Hamilton SR; Hylind LM; Trimbath JD; Geiman DE; Judge KR; Hubbard W; Offerhaus GJ; Yang VW
    Gastroenterology; 2004 Feb; 126(2):425-31. PubMed ID: 14762779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
    Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F
    Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
    Schnitzler M; Dwight T; Robinson BG
    Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal cancer after prolonged sulindac chemoprevention. A case report.
    Lynch HT; Thorson AG; Smyrk T
    Cancer; 1995 Feb; 75(4):936-8. PubMed ID: 7842414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
    Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
    Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.